Fig. 2
From: The potential of cystatin C as a predictive biomarker in pulmonary hypertension
Relationship between cystatin C and disease severity. A Correlation (Spearman) with cardiac index, B Correlation (Spearman) with TAPSE, C Correlation (Spearman) with SvO2, D Cystatin C in different WHO-FC (***P < 0.001), E NT-proBNP (stratified by tertile) and cystatin C (***P < 0.001), F Swedish/COMPERA risk stratification and cystatin C. CI, cardiac index; COMPERA, Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension; NT-proBNP, N-terminal pro-brain natriuretic peptide; SvO2, mixed venous oxygen saturation; TAPSE, tricuspid annular plane systolic excursion; WHO-FC, World Health Organization functional class. Presents the relationship between cystatin C levels and disease severity in the context of hemodynamic status, functional class, NT-proBNP and risk stratification